In the world of vaccine manufacturing, achieving the highest level of efficiency and consistent output is imperative. Seen especially when addressing the urgent demand for widespread immunisation, combating infectious diseases, and responding to global health crises. An article published by Cell Culture Dish, outlined the recent innovations in accelerating vaccine production from Vero cells [...]
An exciting progression in the world of artificial meat was announced a few days ago as cultured meat products were officially approved by the USDA for commercial sale in the US. The United States Department of Agriculture (USDA) is the US authority responsible for developing laws and approvals surrounding farming, forestry and food. [...]
Recent studies have identified the increasingly prevalent advantages of microcarriers when used in the production of Extracellular Vesicles (EVs), in particular, exosomes. These are used for intercellular communication, cell-to-cell signalling, tissue repair and various other purposes. This article gives a summary of these respective papers, both published within the past few years, which [...]
An article published yesterday by Genetic Engineering & Biotechnology News (GEN) placed Smart MCs in the spotlight as a key Australian player in the bioprocessing sphere. The article features an exclusive interview with Smart MCs CEO Payar Radfar, discussing the company’s achievement securing a major government grant for an automated production line. Industry [...]
Following an invigorating and insightful event, Smart MCs has returned from the 2023 International Society for Cell & Gene Therapy (ISCT) Conference, held in Paris, France. With the aim to collaborate among industry leaders, discover new innovations in the field of life sciences, and explore new business opportunities [...]
A global competition conducted by XPRIZE titled ‘Feed the Next Billion’ (FTNB), has announced its six finalists for companies in the alternative meat industry. XPRIZE is a non-profit organisation set up for the purpose of running competitions to award industry leaders for seeking to solve various global problems. One notable finalist was CellX, [...]
An article recently published by GEN describes the unique benefits of stem cells when treating Multiple Sclerosis. Such discoveries support a growing demand for stem cell therapies and clinical applications of such techniques in the future. Supporting this requirement calls for higher adherent quantities of stem cells in clinical settings, therefore microcarriers are [...]
We are excited to announce Smart MCs will be exhibiting at the International Society for Cell & Gene Therapy (ISCT) 2023 Global Conference in Paris, France. Visit their website here to learn more. While there, we will be showcasing our research in the field of biotechnology and showcasing our microcarrier products to other [...]
Smart MCs, a biotech startup born out of the University of Technology Sydney (UTS) ecosystem, has been awarded an Accelerating Commercialisation government grant for their scaled up microcarrier production line, a project totalling $600K. Smart MCs has been awarded the Accelerating Commercialisation Grant by the [...]
An article published by The Scientist details the benefits between soft and stiff substrates for differing stem cell applications. See Original Article. Mesenchymal stem cells (MSCs) possess enormous potential as they can differentiate into various types of cells including bone, cartilage, muscle, and fat. Recent research suggests that the stiffness of the extracellular environment [...]
